Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients.

Batbold BatsaikhanChing-I HuangMing-Lun YehChung-Feng HuangYi-Hung LinPo-Cheng LiangMing-Yen HsiehYi-Ching LinJee-Fu HuangWan-Long ChuangJin-Ching LeeMing-Lung YuHsing-Tao KuoChia-Yen Dai

Published in: PloS one (2022)

The prevalence of the persistent cryoglobulinemia is 34.5% after completing antiviral therapy and it is associated with advanced fibrosis, also HCV clearance.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
hepatitis c virus
liver fibrosis
prognostic factors
risk factors
human immunodeficiency virus
patient reported outcomes
cell therapy
smoking cessation